Double blind, randomised, placebo controlled, crossover, multicentre study to determine the efficacy of a 0.1% (w/v) sodium hyaluronate solution (Fermavisc) in the treatment of dry eye syndrome.

Source:http://linkedlifedata.com/resource/pubmed/id/10502570

Download in:

View as

General Info

PMID
10502570